Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing aldesleukin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aldesleukin (substance) |
Inferred relationship |
Some |
1 |
Aldesleukin adverse reaction (disorder) |
Causative agent (attribute) |
True |
Aldesleukin (substance) |
Inferred relationship |
Some |
1 |
Allergy to aldesleukin |
Causative agent (attribute) |
False |
Aldesleukin (substance) |
Inferred relationship |
Some |
|
Aldesleukin 18megaunits powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aldesleukin (substance) |
Inferred relationship |
Some |
|
Allergy to aldesleukin |
Causative agent (attribute) |
True |
Aldesleukin (substance) |
Inferred relationship |
Some |
1 |
Product containing only aldesleukin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aldesleukin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aldesleukin 22 million unit/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aldesleukin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aldesleukin 22 million unit/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aldesleukin (substance) |
Inferred relationship |
Some |
1 |
Product containing only aldesleukin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aldesleukin (substance) |
Inferred relationship |
Some |
1 |
Product containing aldesleukin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aldesleukin (substance) |
Inferred relationship |
Some |
1 |